Literature DB >> 21161309

Chronic cerebro-spinal venous insufficiency (CCSVI) and multiple sclerosis.

A Ghezzi1, G Comi, A Federico.   

Abstract

Multiple sclerosis (MS) is an inflammatory demyelinating disease of the CNS caused by the interplay of genetic and environmental factors. In the last years, it has been suggested that an abnormal venous drainage due to stenosis or malformation of the internal jugular and/or azygous veins may play a major pathogenetic role in MS. This abnormality called chronic cerebro-spinal venous insufficiency (CCSVI) could result in increased permeability of blood brain barrier, local iron deposition and secondary multifocal inflammation. In the present paper, literature data in favour and against this hypothesis are reported. A great variability of CCSVI has been found in both MS patients (ranging from 0 to 100%) and in control subjects (from 0 to 23%). This large variability is explained by methodological aspects, problems in assessing CCSVI, and differences among clinical series. It is urgent to perform appropriate epidemiological studies to define the possible relationship between CCSVI and MS.

Entities:  

Mesh:

Year:  2010        PMID: 21161309     DOI: 10.1007/s10072-010-0458-3

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


  39 in total

1.  Venous abnormalities and multiple sclerosis: another breakthrough claim?

Authors:  Jane Qiu
Journal:  Lancet Neurol       Date:  2010-05       Impact factor: 44.182

2.  Normal CSF ferritin levels in MS suggest against etiologic role of chronic venous insufficiency.

Authors:  V Worthington; J Killestein; M J Eikelenboom; C E Teunissen; F Barkhof; C H Polman; B M J Uitdehaag; A Petzold
Journal:  Neurology       Date:  2010-09-29       Impact factor: 9.910

Review 3.  Environmental risk factors for multiple sclerosis. Part II: Noninfectious factors.

Authors:  Alberto Ascherio; Kassandra L Munger
Journal:  Ann Neurol       Date:  2007-06       Impact factor: 10.422

4.  MS and autoimmune disorders.

Authors:  G C Ebers
Journal:  Neurogenetics       Date:  2008-10-24       Impact factor: 2.660

5.  Hemodynamic patterns of chronic cerebrospinal venous insufficiency in multiple sclerosis. Correlation with symptoms at onset and clinical course.

Authors:  I Bartolomei; F Salvi; R Galeotti; E Salviato; M Alcanterini; E Menegatti; M Mascalchi; P Zamboni
Journal:  Int Angiol       Date:  2010-04       Impact factor: 2.789

Review 6.  Venous collateral circulation of the extracranial cerebrospinal outflow routes.

Authors:  Paolo Zamboni; Giuseppe Consorti; Roberto Galeotti; Sergio Gianesini; Erica Menegatti; Giovanna Tacconi; Francesco Carinci
Journal:  Curr Neurovasc Res       Date:  2009-08-01       Impact factor: 1.990

7.  Age-related disability in multiple sclerosis.

Authors:  Maria Trojano; Maria Liguori; Giovanni Bosco Zimatore; Roberto Bugarini; Carlo Avolio; Damiano Paolicelli; Fabrizio Giuliani; Francesca De Robertis; Maria Giovanna Marrosu; Paolo Livrea
Journal:  Ann Neurol       Date:  2002-04       Impact factor: 10.422

8.  A prospective open-label study of endovascular treatment of chronic cerebrospinal venous insufficiency.

Authors:  Paolo Zamboni; Roberto Galeotti; Erica Menegatti; Anna Maria Malagoni; Sergio Gianesini; Ilaria Bartolomei; Francesco Mascoli; Fabrizio Salvi
Journal:  J Vasc Surg       Date:  2009-12       Impact factor: 4.268

9.  Multiple sclerosis.

Authors:  Alastair Compston; Alasdair Coles
Journal:  Lancet       Date:  2008-10-25       Impact factor: 79.321

Review 10.  The challenge of multiple sclerosis: how do we cure a chronic heterogeneous disease?

Authors:  Howard L Weiner
Journal:  Ann Neurol       Date:  2009-03       Impact factor: 10.422

View more
  5 in total

1.  Cerebrospinal fluid flow dynamics in patients with multiple sclerosis: a phase contrast magnetic resonance study.

Authors:  Y Gorucu; S Albayram; B Balci; Z I Hasiloglu; K Yenigul; F Yargic; Z Keser; F Kantarci; A Kiris
Journal:  Funct Neurol       Date:  2011 Oct-Dec

2.  Percutaneous transluminal angioplasty for treatment of chronic cerebrospinal venous insufficiency (CCSVI) in people with multiple sclerosis.

Authors:  Vanitha A Jagannath; Eugenio Pucci; Govindaraj V Asokan; Edward W Robak
Journal:  Cochrane Database Syst Rev       Date:  2019-05-31

3.  Chronic cerebrospinal venous insufficiency in multiple sclerosis: clinical correlates from a multicentre study.

Authors:  Stefano Bastianello; Alfredo Romani; Gisela Viselner; Enrico Colli Tibaldi; Elisabetta Giugni; Marta Altieri; Pietro Cecconi; Laura Mendozzi; Massimiliano Farina; Donatella Mariani; Antonio Galassi; Claudio Quattrini; Marcello Mancini; Vincenzo Bresciamorra; Angela Lagace; Sandy McDonald; Giorgio Bono; Roberto Bergamaschi
Journal:  BMC Neurol       Date:  2011-10-26       Impact factor: 2.474

4.  Cerebrospinal Fluid Dynamics in Patients with Multiple Sclerosis: The Role of Phase-Contrast MRI in the Differential Diagnosis of Active and Chronic Disease.

Authors:  Serkan Öner; Ayşegül Sağır Kahraman; Cemal Özcan; Zeynep Maraş Özdemir; Serkan Ünlü; Özden Kamışlı; Zülal Öner
Journal:  Korean J Radiol       Date:  2018-01-02       Impact factor: 3.500

5.  Polymorphisms in the genes coding for iron binding and transporting proteins are associated with disability, severity, and early progression in multiple sclerosis.

Authors:  Donato Gemmati; Giulia Zeri; Elisa Orioli; Francesca E De Gaetano; Fabrizio Salvi; Ilaria Bartolomei; Sandra D'Alfonso; Claudia Dall'osso; Maurizio A Leone; Ajay V Singh; Rosanna Asselta; Paolo Zamboni
Journal:  BMC Med Genet       Date:  2012-08-10       Impact factor: 2.103

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.